Remote Patient Monitoring in Pediatric Obesity

March 13, 2023 updated by: University of Mississippi Medical Center

Examining the Use of a Remote Patient Monitoring System in Pediatric Obesity

The goal of this study is to examine the feasibility and efficacy of a remote patient monitoring system for children who are obese.

Study Overview

Status

Completed

Conditions

Detailed Description

Pediatric obesity is a critical public health issue, as almost one-third of U.S. youth are overweight and about 17% are obese. Childhood obesity is associated with numerous co-morbid health conditions and psychological maladjustment and medical costs associated with treatment are staggering. Mississippi has the highest rates of overweight and obesity in youth 2 to 19 years of age (over 44%). There is an important need for research to focus on treatments that prevent the development of chronic medical conditions in children at risk, specifically those who are obese and receiving specialty care to reduce morbidity and mortality.

Standard care in multidisciplinary pediatric obesity clinics results in improved weight status in some youth. Remote patient monitoring system (RPMS) technology facilitates patient observations outside of clinical settings; thus, increasing access to medical information and medical care, and reducing health care costs. Use of RPMS in adult chronic illness populations has resulted in improved health outcomes but the implementation and examination of RPMS in pediatric populations has been limited. Mississippi is a rural state, which limits access to medical care in pediatric specialty clinics. The implementation of novel, technology-based strategies is needed to supplement current care to prevent long-term morbidity and reduce health care costs. There is a significant need to examine whether a RPMS is feasible and efficacious in a pilot sample of youth who are obese, which will provide support for larger external grant applications further evaluating the RPMS, as well as to inform clinical care in Mississippi and across the country.

Purpose The main objective of this study is to pilot test a RPMS designed to provide supplemental health care to youth who are obese and receiving specialty medical care in a multidisciplinary pediatric obesity clinic. An open trial of the RPMS will enroll 50 children 8 to 17 years of age who are obese and attending a multidisciplinary pediatric obesity clinic and their parents. During the study, participating youth will receive standard care in the clinic and the RPMS, which will consist of an iPad, weight scale, and pedometer, to use for a 3-month period. The initial feasibility of providing the RPMS in combination with standard clinical care will be evaluated, as well as patient satisfaction. The initial efficacy of the RPMS at improving health related outcomes will also be examined. Families will complete pre-treatment (baseline), post-treatment (Month 3), and three month follow-up (Month 6) assessments consisting of weight status, dietary intake, physical activity, health-related quality of life, self-efficacy, and the home-food environment. Health outcomes (e.g., blood pressure, hemoglobin A1c, glucose) routinely assessed through standard medical care in the clinic will be obtained from child medical charts.

Specific Aims

The goals of the current study are to:

  • Assess initial feasibility and satisfaction of implementing a RPMS with children attending a multidisciplinary pediatric obesity clinic.

    o Hypothesis: High feasibility is expected with use of the RPMS and satisfaction rates over 75%.

  • Examine initial efficacy of using the RPMS for three months in youth attending a multidisciplinary pediatric obesity clinic (N = 50).

    • Hypothesis 1.1: After the 3-month period and at follow-up, children will exhibit improved weight status, blood pressure, glucose, A1c, dietary intake, physical activity, health-related quality of life, and self-efficacy compared to pre-treatment.
    • Hypothesis 1.2: Parents will report improved child health-related quality of life and home-food environment after the 3-month treatment and follow-up period compared to pre-treatment.

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Mississippi
      • Jackson, Mississippi, United States, 39216
        • University of Mississippi Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • child 8 to 17 years of age attending an outpatient pediatric obesity clinic visit,
  • child weight status in the obese range (body mass index equal to or above the 95th percentile for age and gender)
  • parent and child are fluent in English.

Exclusion Criteria:

  • child or parent history of cognitive impairment (developmental delay or intellectual disability) by parent report that would impact ability to understand and complete questionnaires or interact with the RPMS
  • child medical condition reported by parents that may prohibit wearing of the actigraph device (e.g., pacemaker).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Remote Patient Monitoring
Families participating in the study will receive standard medical care as well as the Remote Patient Monitoring System.
Families participating in the study will receive standard medical care as well as the RPMS. The RPMS was developed in collaboration with the University of Mississippi Medical Center (UMMC) Center of Telehealth. Patients enrolled in this open trial of the RPMS will interact with the RPMS system on a daily basis and with UMMC's Center for Telehealth nurse care coordinators and research and clinical staff on an as needed basis. The RPMS will provide patients with include an electronic tablet (i.e., iPad) and the ability to receive data from the patient's weight scale and pedometer. Patients will be asked to wear the pedometer daily to track engagement in physical activity and weigh themselves weekly to track weight during the 3 month period. Educational information specific to pediatric obesity and healthy eating and engagement in physical activity will be presented daily through brief presentations and video clips.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of using the RPMS
Time Frame: Post-Treatment (3 months)
percent of queries answered and percent of health data collected from the RPMS via the weight scale and pedometer
Post-Treatment (3 months)
Satisfaction with using the RPMS
Time Frame: Post-Treatment (3 months)
ratings from child and parent satisfaction questionnaire developed for use in the study
Post-Treatment (3 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Status
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
BMI z-score change
Post-Treatment (3 months) and Follow-up (6 months)
Blood Pressure
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
Systolic and Diastolic clinic assessed
Post-Treatment (3 months) and Follow-up (6 months)
Glucose
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
clinic assessed
Post-Treatment (3 months) and Follow-up (6 months)
A1c
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
clinic assessed
Post-Treatment (3 months) and Follow-up (6 months)
Dietary Intake
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
24 hour dietary recall
Post-Treatment (3 months) and Follow-up (6 months)
Physical Activity
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
actigraph assessed
Post-Treatment (3 months) and Follow-up (6 months)
Health-related Quality of Life
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
child and parent report from PedsQL
Post-Treatment (3 months) and Follow-up (6 months)
Self-efficacy
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
Child Report - combined summed total scores from Child Dietary Self-Efficacy Scale and Self-Efficacy for Physical Activity Scale, total scores range from 20-60, higher scores indicate higher self efficacy
Post-Treatment (3 months) and Follow-up (6 months)
Home food environment
Time Frame: Post-Treatment (3 months) and Follow-up (6 months)
Parent-report
Post-Treatment (3 months) and Follow-up (6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2019

Primary Completion (Actual)

September 30, 2021

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

July 12, 2019

First Submitted That Met QC Criteria

July 18, 2019

First Posted (Actual)

July 23, 2019

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 13, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2017-0083

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Obesity

Clinical Trials on Remote Patient Monitoring

Subscribe